As Global Head of Operations, Dr. Elliott is responsible for all operational department activities: regulatory affairs, medical affairs, biometrics, project management, and monitoring.
Dr. Elliott served 5 years in academia where he worked in a Clinical Respiratory Physiology laboratory. During his time in academia, he worked as part of an investigator team performing phase 1 studies for MSD and Glaxo. He went on to be a CRA and progressed into managerial roles within the UK before taking on global roles in CRA management, operational oversight, and quality support, where he worked closely with Quality Assurance and Training departments. Prior to joining Clintec, Dr. Elliott worked within Wyeth and Pfizer.
Dr. Elliott has a special interest in eClinical systems and the use of technology to improve the conduct and design of clinical trials and overall quality of data. He is also passionate about the use of risk-based approaches to clinical studies and integrating patient-centric approaches within clinical protocols.
Throughout his career, Dr. Elliott has been involved in numerous therapeutic areas including CNS, Endocrinology and Metabolism, Transplantation, Cardiovascular, Oncology, Orthopaedics, Women’s Health, Vaccines for the pharmaceutical, biotech, and medical device industries.
Dr. Craig Elliott holds a Ph.D. in Respiratory Physiology.